• Explore /
  • Poster
  • / Inotuzumab ozogamicin (IO) combined with mini-hyper-CVD as salvage therapy for patients (pts) with R/R acute lymphoblastic leukemia (ALL).

Inotuzumab ozogamicin (IO) combined with mini-hyper-CVD as salvage therapy for patients (pts) with R/R acute lymphoblastic leukemia (ALL).

Abstract Poster

Authors

null

Rita Assi

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Rita Assi , Hagop M. Kantarjian , Farhad Ravandi , Susan Mary O'Brien , Partow Kebriaei , Deborah A. Thomas , Guillermo Garcia-Manero , Issa F. Khouri , Richard E. Champlin , Tapan M. Kadia , Jorge E. Cortes , Nitin Jain , Marina Konopleva , Rita Khouri , Zeev Estrov , Koichi Takahashi , Koji Sasaki , Jovitta Jacob , Rebecca Garris , Elias Jabbour

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Acute Leukemia

Clinical Trial Registration Number

NCT01371630

Citation

J Clin Oncol 35, 2017 (suppl; abstr 7025)

DOI

10.1200/JCO.2017.35.15_suppl.7025

Abstract #

7025

Poster Bd #

225

Abstract Disclosures

Similar Posters

First Author: Nicholas James Short

First Author: Elias Jabbour

Poster

2013 ASCO Quality Care Symposium

Improving the care of acute lymphocytic leukemia (ALL) at a large county hospital.

Improving the care of acute lymphocytic leukemia (ALL) at a large county hospital.

First Author: Meghan Sri Karuturi

First Author: Nicholas James Short